Inhibition of MAC30 exerts antitumor effects in nasopharyngeal carcinoma via affecting the Akt/GSK‐3β/β‐catenin pathway
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Biochemical and Molecular Toxicology"
DOI: 10.1002/jbt.23061
Abstract: Meningioma‐associated protein 30 (MAC30) is a vital modulator of malignant transformation in numerous cancers. Yet, the involvement of MAC30 in nasopharyngeal carcinoma (NPC) is undetermined. This study was devoted to the study of the function… read more here.
Keywords: inhibition; mac30; via affecting; catenin ... See more keywords
Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22631
Abstract: Over-expressed meningioma-associate protein (MAC30) in tissues was associated with malignant tumor differentiation, metastasis and poor prognosis. However, the attention of MAC30 in pleural effusion from lung tumor is insufficient. Our retrospective study was prepared to… read more here.
Keywords: mpe; nsclc; mac30; malignant pleural ... See more keywords
The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.
Sign Up to like & getrecommendations! Published in 2017 at "Future oncology"
DOI: 10.2217/fon-2017-0426
Abstract: AIM We aimed to investigate a practical profile of MAC30 on chemotherapeutic response in gastric cancer (GC). PATIENTS & METHODS We elected 87 GC patients receiving platinum-based chemotherapy in this study. MAC30 levels in tumor… read more here.
Keywords: receiving platinum; based chemotherapy; mac30; platinum based ... See more keywords